In our study we found a significant increase of the levels of IL-6 in the blood of menopausal women with MetS in response to 10 and 20 WBC treatments, but without a concomitant change in CRP levels, indicating the anti-inflammatory effect of IL-6 in this situation. This evidence concerns the gene IL6 and metabolic syndrome.